SEC Company Response from Tectonic Therapeutic, Inc. (TECX) (CIK 0001681087) (TECX) — Jun 18, 2018
Tectonic Therapeutic, Inc. (TECX) (CIK 0001681087)
Date: June 18, 2018 · CIK: 0001681087 · Accession: 0001193125-18-195618
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-225213
Letter
Re: AVROBIO, Inc.
June 18, 2018
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Registration Statement on Form S-1 (File No. 333-225213) (the “Registration Statement”)
Ladies and Gentleman:
In connection with the above-referenced Registration Statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), we hereby join in the request of AVROBIO, Inc. that the effective date of the Registration Statement be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on June 20, 2018, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Act, please be advised that we and the other prospective underwriters have distributed approximately 2,911 copies of the preliminary prospectus dated June 11, 2018 (the “Preliminary Prospectus”) through the date hereof to underwriters, dealers, institutions and others.
In connection with the Preliminary Prospectus distribution for the above-referenced issue, we hereby confirm that we are, and the other prospective underwriters have confirmed that they are, complying with the 48-hour requirement as promulgated by Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
[Remainder of page intentionally left blank]
Very truly yours,
MORGAN STANLEY & CO. LLC
Show Raw Text
CORRESP 1 filename1.htm CORRESP June 18, 2018 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: AVROBIO, Inc. Registration Statement on Form S-1 (File No. 333-225213) (the “Registration Statement”) Ladies and Gentleman: In connection with the above-referenced Registration Statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), we hereby join in the request of AVROBIO, Inc. that the effective date of the Registration Statement be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on June 20, 2018, or as soon thereafter as practicable. Pursuant to Rule 460 under the Act, please be advised that we and the other prospective underwriters have distributed approximately 2,911 copies of the preliminary prospectus dated June 11, 2018 (the “Preliminary Prospectus”) through the date hereof to underwriters, dealers, institutions and others. In connection with the Preliminary Prospectus distribution for the above-referenced issue, we hereby confirm that we are, and the other prospective underwriters have confirmed that they are, complying with the 48-hour requirement as promulgated by Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. [Remainder of page intentionally left blank] Very truly yours, MORGAN STANLEY & CO. LLC COWEN AND COMPANY, LLC WELLS FARGO SECURITIES, LLC As Representatives of the several Underwriters MORGAN STANLEY & CO. LLC. By: /s/ Albert Hwang Name: Albert Hwang Title: Managing Director COWEN AND COMPANY LLC By: /s/ Jason Fenton Name: Jason Fenton Title: Managing Director WELLS FARGO SECURITIES, LLC By: /s/ David Herman Name: David Herman Title: Director [Signature Page to Request for Acceleration of Effectiveness]